Aktie A2AFQ6 OPIANT PHARMACEUTICALS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Opiant Pharmaceuticals, Inc.

Aktien

A2AFQ6

US6837501039

OPNT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Indivior completes acquisition of Opiant Pharmaceuticals
Indivior Wraps Up Deal to Buy Opiant Pharmaceuticals
OPIANT PHARMACEUTICALS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
Opiant Pharmaceuticals, Inc.(NasdaqCM:OPNT) dropped from NASDAQ Composite Index
Opiant Pharmaceuticals, Inc.(NasdaqCM:OPNT) dropped from S&P TMI Index
Indivior PLC completed the acquisition of Opiant Pharmaceuticals, Inc. from a group of shareholders.
OPIANT PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
OPIANT PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
Indivior Wins US Regulatory Nod To Acquire Opiant Pharmaceuticals
OPIANT PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC
Bolsa de Madrid: Jerome vuelve en la segunda semana
Jerome revient en deuxième semaine
En Direct des Marchés : BNP Paribas, TotalEnergies, L'Oréal, Scor, Casino, CVS, Bayer, Siemens, BP...
Indivior announces expiry of waiting period for Opiant purchase
Opiant Pharmaceuticals Says Waiting Period Expires for Proposed Takeover by Indivior Expires
Indivior Nears Acquisition of Opiant Pharmaceuticals
Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC
Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC
Warren tells FTC she is "particularly concerned" about Amgen and Indivior deals
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2AFQ6 Aktie
  4. Nachrichten Opiant Pharmaceuticals, Inc.
  5. Andere Sprachen
: